Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Energy Fuels Aktie: Achtung, Aufholpotenzial! (Aktiencheck) +++ ENERGY FUELS Aktie -3,11%

AVISTA Aktie

 >AVISTA Aktienkurs 
32.5 EUR    (Tradegate)
Ask: 32.6 EUR / 153 Stück
Bid: 32.4 EUR / 154 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
AVISTA Aktie über LYNX handeln
>AVISTA Performance
1 Woche: +2,2%
1 Monat: -5,5%
3 Monate: -14,5%
6 Monate: -8,5%
1 Jahr: +3,8%
laufendes Jahr: -6,6%
>AVISTA Aktie
Name:  AVISTA CORP.
Land:  USA
Sektor:  Versorger
ISIN/ Wkn:  US05379B1070 / 856142
Symbol/ Ticker:  AV6 (Frankfurt) / AVA (NYSE)
Kürzel:  FRA:AV6, ETR:AV6, AV6:GR, NYSE:AVA
Index:  -
Webseite:  https://investor.avistaco..
Marktkapitalisierung:  2590 Mio. EUR
Umsatz:  1682.45 Mio. EUR
EBITDA:  524.58 Mio. EUR
Gewinn je Aktie:  1.751 EUR
Schulden:  2631.52 Mio. EUR
Liquide Mittel:  15.53 Mio. EUR
Umsatz-/ Gewinnwachstum:  1.3% / 11.3%
KGV/ KGV lG:  15.92 / 14.56
KUV/ KBV/ PEG:  1.53 / 1.14 / 2.65
Gewinnm./ Eigenkapitalr.:  9.66% / 7.27%
Dividende je Aktie:  1.787 EUR
Dividendenrendite/ -schätzung:  5.5% / 5.22%
Div. Historie:  13.05.25 - 0.4418€
26.02.25 - 0.46609€
>weitere anzeigen...
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 38.728 USD.
Suchwörter:  AVISTA
Letzte Datenerhebung:  04.07.25
>AVISTA Eigentümer
Aktien: 80.56 Mio. St.
f.h. Aktien: 79.75 Mio. St.
Insider Eigner: 0.84%
Instit. Eigner: 88.29%
>AVISTA Peer Group

 
24.06.25 - 22:33
AVISTA HEALTHCARE PARTNERS CLOSES CONTINUATION FUND FOR GCM (PR Newswire)
 
Goldman Sachs Alternatives served as lead investor; additional investments from BlackRock Secondaries & Liquidity Solutions NEW YORK, June 24, 2025 /PRNewswire/ -- Avista Healthcare Partners ("Avista"), a leading private equity firm focused exclusively on healthcare, today announced the......
13.06.25 - 02:01
Insiderhandel: Vice President verkauft Aktien von Avista im Wert von 38728 USD (Insiderkauf)
 
Kinney, Scott J. - Vorstand - Tag der Transaktion: 2025-06-12...
10.06.25 - 01:24
Avista reaches all-party, all issues settlement in Idaho general rate cases (GlobeNewswire EN)
 
If approved, new rates would take effect beginning Sept. 2025 and Sept. 2026 If approved, new rates would take effect beginning Sept. 2025 and Sept. 2026...
04.06.25 - 00:33
Avista enacts temporary change to power line operations for summer (GlobeNewswire EN)
 
Fire Safety mode increases power line sensitivity ahead of the 2025 wildfire season. Fire Safety mode increases power line sensitivity ahead of the 2025 wildfire season....
30.05.25 - 19:33
Avista issues all-source request for proposals for new energy and capacity resources along with Demand Response (GlobeNewswire EN)
 
Energy solutions sought to add capacity to Avista's portfolio Energy solutions sought to add capacity to Avista's portfolio...
11.05.25 - 21:18
XFRA: DIVIDEND/INTEREST INFORMATION - 13.05.2025 - US05379B1070 (XETRA)
 
Das Instrument AV6 US05379B1070 AVISTA CORP. EQUITY wird cum Dividende/Zinsen gehandelt am 12.05.2025 und ex Dividende/Zinsen am 13.05.2025 The instrument AV6 US05379B1070 AVISTA CORP. EQUITY has its pre-dividend/interest day on 12.05.2025 and its ex-dividend/interest day on 13.05.2025...
08.05.25 - 13:02
Avista Therapeutics Presents In Vivo Data for its AAV Capsid in Inherited Retinal Diseases at Association for Research in Vision and Ophthalmology 2025 Annual Meeting (PR Newswire)
 
Potential best-in-class intravitreal capsid demonstrates Retinoschisin expression similar to endogenous levels in X-linked retinoschisis IND-enabling studies are ongoing to support filing expected in early 2026 PITTSBURGH, May 8, 2025 /PRNewswire/ -- Avista Therapeutics, a......
08.05.25 - 13:00
Zacks.com featured highlights include Nomad Foods, AerSale, BJ′s Restaurants, AXIS Capital and Avista (Zacks)
 
Nomad Foods, AerSale, BJ's Restaurants, AXIS Capital and Avista are part of the Zacks Screen of the Week article....
07.05.25 - 21:45
Avista outlines $3B infrastructure investment through 2029 amid wildfire mitigation efforts (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 13:24
Avista GAAP EPS of $0.98 misses by $0.05, revenue of $603M misses by $28.85M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 13:06
Avista Corp. Reports Financial Results for the First Quarter of 2025, Confirms 2025 Earnings Guidance (GlobeNewswire EN)
 
SPOKANE, Wash., May 07, 2025 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today announced financial results for the first quarter of 2025. Net income and earnings per diluted share for the first quarter of 2025 compared to the first quarter of 2024 are presented in the table below (dollars in millions, except per-share data):...
06.05.25 - 17:30
Avista Q1 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.05.25 - 23:42
Avista declares $0.49 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.05.25 - 23:36
Avista Corp. Board Declares Common Stock Dividend (GlobeNewswire EN)
 
SPOKANE, Wash., May 01, 2025 (GLOBE NEWSWIRE) -- Avista Corp.'s (NYSE: AVA) board of directors has declared a quarterly dividend of $0.49 per share on the company's common stock. The common stock dividend is payable June 13, 2025, to shareholders of record at the close of business on May 13, 2025....
30.04.25 - 13:01
Avista Therapeutics Announces Oral Presentation at Association for Research in Vision and Ophthalmology 2025 Annual Meeting (PR Newswire)
 
PITTSBURGH, April 30, 2025 /PRNewswire/ -- Avista Therapeutics, a pre-clinical-stage biotechnology company developing innovative gene therapies for rare ophthalmic conditions, today announced that the Company will present data highlighting the potential of its scAAVengr-HUnT platform to......
21.04.25 - 18:03
Avista Foundation awards 58 grants supporting health and human services (GlobeNewswire EN)
 
So far this year, the Avista Foundation has awarded over $316,000 to support local communities. So far this year, the Avista Foundation has awarded over $316,000 to support local communities....
09.04.25 - 22:09
Avista Corp. First Quarter 2025 Earnings Conference Call and Webcast Announced (GlobeNewswire EN)
 
SPOKANE, Wash., April 09, 2025 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) will hold its quarterly conference call and webcast to discuss first quarter 2025 results on Wednesday, May 7, 2025, at 12:30 p.m. Eastern Daylight Time. A news release with first quarter 2025 earnings information will be issued at 7:05 a.m. Eastern Daylight Time on May 7, 2025....
08.04.25 - 12:00
Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE (Zacks)
 
ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE have been highlighted in this Screen of The Week article....
07.04.25 - 19:45
Avista (AVA) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
 
Avista (AVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
07.04.25 - 16:00
Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO (Zacks)
 
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Expand Energy, Avista & Contango are well-poised to gain....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!